Clinical characteristics and outcomes of COVID-19 in kidney transplant recipients
R. O. Kantariya(Regional Clinical Research), A. A. Gaydarova(Kidney Research UK), Е. И. Прокопенко(Regional Clinical Research), A. R. Karapityan(Regional Clinical Research), А. А. Аммосов(Regional Clinical Research), Ya. G. Moysyuk(Regional Clinical Research), A. V. Makevnina(Regional Clinical Research)
Transplantologiya The Russian Journal of Transplantation
December 15, 2021
Cited by 2
Related Papers
Randomized Trial of Micafungin for the Prevention of Invasive Fungal Infection in High-Risk Liver Transplant Recipients
|Clinical Infectious Diseases|2014|81
Kidney from uncontrolled donors after cardiac death with one hour warm ischemic time: resuscitation by extracorporal normothermic abdominal perfusion “<i>in situ</i>” by leukocytes‐free oxygenated blood
|Clinical Transplantation|2010|39
Machine Perfusion as a Tool to Select Kidneys Recovered From Uncontrolled Donors After Cardiac Death
|Transplantation Proceedings|2008|22
The Use of Oxygenated Perfluorocarbonic Emulsion for Initial In Situ Kidney Perfusion
|Transplantation Proceedings|2008|19
LIVER TRANSPLANTATION IN CHILDREN: SIX-YEAR EXPERIENCE ANALYSIS
|Russian Journal of Transplantology and Artificial Organs|2014|17